The Patent Finder

Alkermes PLC

Also on record
Records under this name other than patents Alkermes PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Alkermes PLC

PatentTitleStatus Expires Confidence
US 11,980,652Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,945,870Immunomodulatory IL-2 Agents in Combination with Immune Checkpoint Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,834,483Immunostimulatory Agents in Combination with Angiogenesis Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,338,293Upar Antibodies and Fusion Proteins with the Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,246,906Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy
Formerly held
Lapsed on the fee record
Ended Feb 15, 2026 · High confidence
Lapsed on the fee recordEnded Feb 15, 2026High confidence
US 11,248,050Immunomodulatory IL-2 Agents in Combination with Immune Checkpoint Inhibitors
Formerly held
Lapsed on the fee record
Ended Feb 15, 2026 · High confidence
Lapsed on the fee recordEnded Feb 15, 2026High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited